US stocks MEIP rose more than 33% today, and its market value rose to US$41.24 million
MEI Pharma (NASDAQ code: MEIP) rose more than 33% today, with a market value of $412.31 million.
Earlier news, Titan Partners Group and the cryptocurrency investment company GSR are jointly leading the strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ code: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, there are over $100 million in funding commitments for this project. Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitget to upgrade Private Wealth Management
Bitget futures and CFD elite portfolios now support customizable profit share cycles
Futures copy trading adds trailing exit and custom copy multiplier features
Bitget PoolX is listing Real Token (RT1) : Lock ETH to get 27,000,000 RT1 airdrop
